{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:59:05Z","timestamp":1789559945244,"version":"build-2803163510"},"reference-count":57,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This research investigated the preventive effects of myrtenol (MYR), fatty acid nanocarriers (FANC), and myrtenol\u2010loaded FANC (MYR\u2009+\u2009FANC) on neurological disturbance, stroke volume, the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and tumor necrosis factor\u2010alpha (TNF\u2010\u03b1) in the brain with ischemia<jats:bold>\u2013<\/jats:bold>reperfusion injuries induced by middle cerebral artery occlusion (MCAO) in rats. Seventy two Wistar male rats were divided into six main groups. The groups were sham, ischemia<jats:bold>\u2013<\/jats:bold>reperfusion group (MACO), MACO\u2010MYR (50\u2009mg\/kg), MACO\u2010FANC (50 and 100\u2009mg\/kg), and MACO\u2010MYR\u2009+\u2009FANC (50\u2009mg\/kg). Stroke volume, neurological deficit scores, and the brain levels of MDA, SOD, and TNF\u2010\u03b1 were examined with TTC staining, observation, and ELISA, respectively. Pretreatment with MYR, FANC (100\u2009mg\/kg), and MYR\u2009+\u2009FANC reduced the neurological deficit score and cerebral infarction volume. MYR, FANC (100\u2009mg\/kg), and MYR\u2009+\u2009FANC pretreatment increased and decreased brain SOD and MDA levels compared to MACO group, respectively. The TNF\u2010\u03b1 level decreased in the MYR\u2009+\u2009FANC group compared to MCAO and MCAO\u2010MYR groups in the brain. The use of FANC (100\u2009mg\/kg), MYR, and MYR\u2009+\u2009FANC has protective effects against oxidative stress and ischemia<jats:bold>\u2013<\/jats:bold>reperfusion injury. FANC probably improve the bioavailability of MYR, as MYR+ FANC had more therapeutic effects on the reduction of ischemia\u2013reperfusion injuries, inflammation, and oxidative stress.<\/jats:p>","DOI":"10.1111\/cbdd.14633","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:59:08Z","timestamp":1727269148000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myrtenol\u2010Loaded Fatty Acid Nanocarriers Protect Rat Brains Against Ischemia\u2013Reperfusion Injury: Antioxidant and Anti\u2010Inflammatory Effects"],"prefix":"10.1111","volume":"104","author":[{"given":"Shima","family":"Karimi\u00a0Afshar","sequence":"first","affiliation":[{"name":"Faculty of Life Sciences and Biotechnology Shahid Beheshti University  Tehran Iran"},{"name":"Physiology Research Center, Institute of Neuropharmacology Kerman University of Medical Sciences  Kerman Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7879-9938","authenticated-orcid":false,"given":"Farzaneh","family":"Rostamzadeh","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Institute of Neuropharmacology Kerman University of Medical Sciences  Kerman Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad\u00a0Reza","family":"Bigdeli","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Biotechnology Shahid Beheshti University  Tehran Iran"},{"name":"Institute for Cognitive and Brain Science Shahid Beheshti University  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mortazavi\u00a0Moghadam","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine Shahid Beheshti University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1824"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.22127\/RJP.2023.381705.2041"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00784\u2010009\u20100267\u20103"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.06.005"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.17.6.1304"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018\u2010019\u201003030\u20107"},{"key":"e_1_2_9_8_1","volume-title":"Brain Ischemia: Basic Concepts and Clinical Relevance","author":"Caplan L. R.","year":"2012"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.125"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3576"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896\u20106273(94)90159\u20107"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp300697h"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2017.12.003"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3791\/62321"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2014.0500294"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2021.07.015"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.090720"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030134"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2741\/222"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.046"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2021.1917626"},{"issue":"4","key":"e_1_2_9_22_1","first-page":"677","article-title":"Adhesion of Lymphocytes to Cerebral Microvascular Cells: Effects of Interferon\u2010Gamma, Tumour Necrosis Factor and Interleukin\u20101","volume":"64","author":"Hughes C.","year":"1988","journal-title":"Immunology"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1875"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00028"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2010.06.003"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.04.055"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms130810478"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1875397301105010021"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.984424"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472\u20108206.2012.01039.x"},{"issue":"16","key":"e_1_2_9_31_1","first-page":"1491","article-title":"JNK3 Involvement in Nerve Cell Apoptosis and Neurofunctional Recovery After Traumatic Brain Injury","volume":"8","author":"Long J.","year":"2013","journal-title":"Neural Regeneration Research"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.20.1.84"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051333"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114498"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612829666221222121041"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.04.010"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004647\u2010199705000\u201000001"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951\u2010016\u20100177\u2010x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07994"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910219"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12291\u2010014\u20100446\u20100"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130103"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2019.1100749"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2017.170"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cjce.23344"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973\u20101296.59960"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2013.56.3.107"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090837"},{"issue":"3","key":"e_1_2_9_49_1","first-page":"289","article-title":"Importance of Solid Lipid Nanoparticles (SLN) in Various Administration Routes and Future Perspectives","volume":"2","author":"Uner M.","year":"2007","journal-title":"International Journal of Nanomedicine"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022034509354455"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2010.03.002"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.01.012"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1139\/y97\u2010146"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S130842"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/35081571"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.09.016"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00053.x"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.834114"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.14633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:55:58Z","timestamp":1727427358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cbdd.14633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/cbdd.14633"],"URL":"https:\/\/doi.org\/10.1111\/cbdd.14633","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"2024-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14633"}}